Page last updated: 2024-10-30

losartan and Menopause

losartan has been researched along with Menopause in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abu-Taha, M1
Rius, C1
Hermenegildo, C1
Noguera, I1
Cerda-Nicolas, JM1
Issekutz, AC1
Jose, PJ1
Cortijo, J1
Morcillo, EJ1
Sanz, MJ1

Other Studies

1 other study available for losartan and Menopause

ArticleYear
Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan.
    Journal of immunology (Baltimore, Md. : 1950), 2009, Jul-15, Volume: 183, Issue:2

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Animals; Benzazepines; Case-Control Studies; Cell Ad

2009